Cargando…
General recommendation for assessment and management on the risk of glucocorticoid-induced osteonecrosis in patients with COVID-19
BACKGROUND/OBJECTIVE: Coronavirus disease 2019 (COVID-19) is a disaster in human medical history and glucocorticoids remain the most promising therapy. Osteonecrosis is a disease caused by reduced intraosseous blood flow to bones in the joints, which will rapidly induce joint destruction. Approximat...
Autores principales: | Li, Wenlong, Huang, Zeqing, Tan, Biao, Chen, Gang, Li, Xugui, Xiong, Kan, Zhu, Ruizheng, Li, Ruihan, Li, Shuwen, Ye, Hengli, Liang, Zhi, Dong, Xiaojun, Zhou, Shijing, Chen, Song, Xi, Haixiang, Cheng, Hao, Xu, Rongpeng, Tu, Shenghao, Chen, Zhe, Qi, Lihua, Song, Jiandong, Xiao, Ruoran, Liu, Huilan, Nan, Qian, Yu, Huiyong, Cui, Hongsheng, Shen, Yanguang, Wang, Chengxiang, Lin, Na, Zhang, Yanqiong, Chen, Weiheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Chinese Speaking Orthopaedic Society
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8526281/ https://www.ncbi.nlm.nih.gov/pubmed/34692412 http://dx.doi.org/10.1016/j.jot.2021.09.005 |
Ejemplares similares
-
Identification and assessment of novel dynamic biomarkers for monitoring non‐traumatic osteonecrosis of the femoral head staging
por: Jia, Yan, et al.
Publicado: (2023) -
Dynamic evolution of osseous structure in osteonecrosis of the femoral head and dynamic collapse risks: a preliminary CT image study
por: Huang, Zeqing, et al.
Publicado: (2020) -
Mechanisms and Molecular Targets of the Tao-Hong-Si-Wu-Tang Formula for Treatment of Osteonecrosis of Femoral Head: A Network Pharmacology Study
por: Fu, Fanyu, et al.
Publicado: (2020) -
Epidemiological Study Based on China Osteonecrosis of the Femoral Head Database
por: Tan, Biao, et al.
Publicado: (2020) -
How to evaluate the clinical outcome of joint-preserving treatment for osteonecrosis of the femoral head: development of a core outcome set
por: Xue, Zhipeng, et al.
Publicado: (2019)